Document regarding Listing Particularss

Cambridge Antibody Tech Group PLC
5 February 2002


Doc Re Listing Particulars relating to the issue of up to 3,658,386 new
ordinary shares of 10 pence each in Cambridge Antibody Technology Group plc in
connection with the offer by 3982904 Canada Inc. (a wholly owned subsidiary of
Cambridge Antibody Technology Group plc) for Drug Royalty Corporation Inc. 

A Copy of the above document has been submitted to the UK Listing Authority,
and will shortly be available for inspection at the UK Listing Authority's
Document Viewing Facility, which is situated at:

Financial Services Authority
25 The North Colonnade
Canary Wharf
London
E14 5HS

Tel. no. (0)20 7676 1000

(Documents will usually be available for inspection within six normal business
hours of this notice being given).


                      This information is provided by RNS
            The company news service from the London Stock Exchange